Mcdonald Partners LLC Adaptive Biotechnologies Corp Transaction History

Mcdonald Partners LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$6.4 - $14.73 $324,441 - $746,722	-50,694 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$10.12 - $28.9 $513,023 - $1.47 Million	50,694 New	50,694 $704,000
Q4 2021 Jan 31, 2022	SELL	$25.17 - $36.85 $1.28 Million - $1.87 Million	-50,694 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$30.02 - $39.87 $330 - $438	11 Added 0.02%	50,694 $1.72 Million
Q2 2021 Nov 24, 2021	SELL	$32.22 - $44.59 $354 - $490	-11 Reduced 0.02%	50,683 $2.07 Million
Q2 2021 Jul 23, 2021	BUY	$32.22 - $44.59 $354 - $490	11 Added 0.02%	50,694 $2.07 Million
Q1 2021 Nov 24, 2021	SELL	$37.26 - $67.74 $409 - $745	-11 Reduced 0.02%	50,683 $2.04 Million
Q1 2021 Apr 15, 2021	SELL	$37.26 - $67.74 $187,045 - $340,054	-5,020 Reduced 9.01%	50,694 $2.04 Million
Q4 2020 Feb 16, 2021	BUY	$45.01 - $65.47 $2.51 Million - $3.65 Million	55,714 New	55,714 $3.29 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Mcdonald Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Mcdonald Partners LLC with notifications on news.